BIOMAT Database Logo BIOMAT Database Logo

Plasma triglyceride and insulin levels in familial hypertriglyceridemia. 1977

J D Brunzell, and E L Bierman

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D002914 Chylomicrons A class of lipoproteins that carry dietary CHOLESTEROL and TRIGLYCERIDES from the SMALL INTESTINE to the tissues. Their density (0.93-1.006 g/ml) is the same as that of VERY-LOW-DENSITY LIPOPROTEINS. Chylomicron
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006946 Hyperinsulinism A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS. Compensatory Hyperinsulinemia,Endogenous Hyperinsulinism,Exogenous Hyperinsulinism,Hyperinsulinemia,Hyperinsulinemia, Compensatory,Hyperinsulinism, Endogenous,Hyperinsulinism, Exogenous
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride

Related Publications

J D Brunzell, and E L Bierman
Plasma lipoproteins, apolipoproteins, and triglyceride metabolism in familial hypertriglyceridemia.
January 1986, Arteriosclerosis (Dallas, Tex.),
J D Brunzell, and E L Bierman
Insulin, obesity, and triglyceride interrelationships in sixteen children with familial hypertriglyceridemia.
January 1977, Pediatric research,
J D Brunzell, and E L Bierman
[Hypertriglyceridemia and plasma insulin in combined familial hyperlipidemia].
November 1997, Revista clinica espanola,
J D Brunzell, and E L Bierman
Plasma triglyceride metabolism in hypertriglyceridemia.
January 1973, Annales de biologie clinique,
J D Brunzell, and E L Bierman
The response of plasma triglyceride, cholesterol, and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridemia.
June 1983, Diabetes,
J D Brunzell, and E L Bierman
Influence of obesity on the relationship between insulin and triglyceride levels in endogenous hypertriglyceridemia.
October 1971, Diabetes,
J D Brunzell, and E L Bierman
Genome-wide scan for quantitative trait loci influencing LDL size and plasma triglyceride in familial hypertriglyceridemia.
November 2003, Journal of lipid research,
J D Brunzell, and E L Bierman
Carbohydrate-induced hypertriglyceridemia: an insight into the link between plasma insulin and triglyceride concentrations.
September 2000, The Journal of clinical endocrinology and metabolism,
J D Brunzell, and E L Bierman
Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.
February 1983, Journal of lipid research,
J D Brunzell, and E L Bierman
Plasma insulin and triglyceride levels after hypothalamic lesions in weanling rats.
June 1969, The American journal of physiology,
Copied contents to your clipboard!